We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
-22.41%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.2B
AUM Growth
-$529M
(-31%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-15.87%
Top 10 Holdings %
Top 10 Hldgs %
48.83%
Holding
40
New
6
Increased
10
Reduced
9
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ironwood Pharmaceuticals
IRWD
|
+$48.8M |
| 2 |
GDS Holdings
GDS
|
+$36.2M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$23.6M |
| 4 |
VeriSign
VRSN
|
+$23.6M |
| 5 |
Shake Shack
SHAK
|
+$23.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$110M |
| 2 |
Zimmer Biomet
ZBH
|
+$92.7M |
| 3 |
DexCom
DXCM
|
+$43.5M |
| 4 |
MSGN
MSG Networks Inc.
MSGN
|
+$34.7M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$29.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.45% |
| 2 | Technology | 15.13% |
| 3 | Consumer Discretionary | 13.34% |
| 4 | Communication Services | 6.41% |
| 5 | Consumer Staples | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCG
26
DELISTED
Wellcare Health Plans, Inc.
WCG
| $18.8M | 1.57% |
+79,816
| New | +$21.4M |
|
27
Centene
CNC
$30.8B
| $18.5M | 1.54% |
+321,218
| New | +$21.5M |
|
28
STAAR Surgical
STAA
$1.21B
| $16.4M | 1.37% |
+514,105
| New | +$20M |
|
29
TG Therapeutics
TGTX
$7.95B
| $15.5M | 1.3% |
3,791,531
+1,601,446
| +73% | +$7.96M |
|
|
CSII
30
DELISTED
Cardiovascular Systems, Inc.
CSII
| $15.3M | 1.27% |
536,128
+68,336
| +15% | +$2.17M |
|
|
PVG
31
DELISTED
PRETIUM RESOURCES INC.
PVG
| $14M | 1.16% |
1,651,328
| – | – |
|
32
Amneal Pharmaceuticals
AMRX
$5.84B
| $13.8M | 1.15% |
1,021,420
-1,621,201
| -61% | -$29.2M |
|
33
Wave Life Sciences
WVE
$1.09B
| $13.1M | 1.09% |
311,393
-104,582
| -25% | -$4.65M |
|
|
34
DexCom
DXCM
$32.3B
| $6.76M | 0.56% |
225,828
-1,371,088
| -86% | -$43.5M |
|
|
35
HCA Healthcare
HCA
$87.2B
| – | – |
-789,399
| Closed | -$110M |
|
36
ScottsMiracle-Gro
SMG
$3.89B
| – | – |
-369,057
| Closed | -$29.1M |
|
37
PUT
Tesla
TSLA
$1.22T
| – | – |
-1,500,000
| Closed | -$26.5M |
|
|
38
Zimmer Biomet
ZBH
$18.2B
| – | – |
-726,297
| Closed | -$92.7M |
|
|
MSGN
39
DELISTED
MSG Networks Inc.
MSGN
| – | – |
-1,346,056
| Closed | -$34.7M |
|
|
ATVI
40
DELISTED
Activision Blizzard
ATVI
| – | – |
-360,000
| Closed | -$29.9M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q4 2018 Portfolio in Review
As of Q4 2018, Bridger Management held 40 positions worth $1.2B, down 31% from $1.73B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bridger Management withdrew a net $190M in Q4 2018, closing 6 positions and reducing 9 holdings. Its most notable exit was HCA Healthcare, an estimated $110M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 47% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in GDS Holdings worth $32.1M.
- Bridger Management's largest Q4 2018 buy was GDS Holdings: 1,389,514 shares worth $32.1M.
- Bridger Management added most to Ironwood Pharmaceuticals in Q4 2018, an estimated $48.8M increase.
- Bridger Management's biggest Q4 2018 reduction was DexCom, cutting an estimated $43.5M.
- Bridger Management fully exited HCA Healthcare in Q4 2018, selling an estimated $110M.
- Bridger Management's ten largest holdings make up 49% of its $1.2B portfolio in Q4 2018.
- Bridger Management opened 6 new positions and closed 6 in Q4 2018.
- Bridger Management's portfolio value fell 31% quarter-over-quarter to $1.2B.
Based on Bridger Management's 13F filing for Q4 2018, filed 14 Feb 2019.